[96a5a0]: / output / allTrials / identified / NCT00002631_identified.json

Download this file

406 lines (406 with data), 20.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
{
"info": {
"nct_id": "NCT00002631",
"official_title": "A PHASE III INTERGROUP RANDOMIZED COMPARISON OF COMBINED MODALITY THERAPY FOR CARCINOMA OF THE ESOPHAGUS: HIGH-DOSE VS CONVENTIONAL-DOSE RADIATION THERAPY",
"inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": "DISEASE CHARACTERISTICS: Biopsy-proven primary squamous cell or adenocarcinoma of the esophagus Clinical Stage T1-4, Nx, M0 disease required Disease entirely confined to the esophagus and periesophageal soft tissue with no tumor extension within 2 cm proximal to the stomach No biopsy-proven invasion of the tracheal-bronchial tree or tracheal-esophageal (TE) fistula Bronchoscopy of tracheal-bronchial tree required for lesions less than 30 cm from the incisors to exclude TE fistula Negative liver biopsy required if liver CT suggestive of metastatic disease Negative biopsy required for enlarged (1.5 cm or greater) retroperitoneal or celiac nodes seen on CT Negative biopsy of clinically or radiographically positive supraclavicular nodes required with cervical primaries No recurrent disease No multiple carcinomas of the esophagus\n\nPATIENT CHARACTERISTICS: Age: 18 and over Performance status: Karnofsky 60%-100% Hematopoietic: WBC at least 4,000 Platelets at least 150,000 Hb at least 10 g/dL Hepatic: Not specified Renal: Creatinine normal OR Creatinine clearance at least 65 mL/min Nutrition: Recommended oral intake requirements (by mouth or tube feeding): More than 1.5 x Basal Energy Expenditure (BEE) measured by Harris- Benedict equation OR More than 1,000 calories/sqm of body surface area (BSA) Intravenous hyperalimentation (recommended if inadequate oral intake): 1.75-2.25 x BEE OR 1,200-1,600 calories/sqm BSA Upper limits may be waived for hypermetabolic patients Other: No second malignancy within 5 years except: Curable nonmelanomatous skin cancer Cervical cancer in situ No pregnant or nursing women\n\nPRIOR CONCURRENT THERAPY: Biologic therapy: No prior or concurrent growth factor administration Chemotherapy: No prior chemotherapy Endocrine therapy: Not specified Radiotherapy: No prior chest irradiation Surgery: No prior resection"
},
"inclusion_lines": [
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [
{
"line": "DISEASE CHARACTERISTICS: Biopsy-proven primary squamous cell or adenocarcinoma of the esophagus Clinical Stage T1-4, Nx, M0 disease required Disease entirely confined to the esophagus and periesophageal soft tissue with no tumor extension within 2 cm proximal to the stomach No biopsy-proven invasion of the tracheal-bronchial tree or tracheal-esophageal (TE) fistula Bronchoscopy of tracheal-bronchial tree required for lesions less than 30 cm from the incisors to exclude TE fistula Negative liver biopsy required if liver CT suggestive of metastatic disease Negative biopsy required for enlarged (1.5 cm or greater) retroperitoneal or celiac nodes seen on CT Negative biopsy of clinically or radiographically positive supraclavicular nodes required with cervical primaries No recurrent disease No multiple carcinomas of the esophagus",
"criterions": [
{
"exact_snippets": "Biopsy-proven primary squamous cell or adenocarcinoma of the esophagus",
"criterion": "primary squamous cell or adenocarcinoma of the esophagus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Clinical Stage T1-4, Nx, M0 disease required",
"criterion": "clinical stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"T1",
"T2",
"T3",
"T4"
]
},
{
"requirement_type": "node involvement",
"expected_value": "Nx"
},
{
"requirement_type": "metastasis",
"expected_value": "M0"
}
]
},
{
"exact_snippets": "Disease entirely confined to the esophagus and periesophageal soft tissue",
"criterion": "disease location",
"requirements": [
{
"requirement_type": "location",
"expected_value": "esophagus and periesophageal soft tissue"
}
]
},
{
"exact_snippets": "no tumor extension within 2 cm proximal to the stomach",
"criterion": "tumor extension",
"requirements": [
{
"requirement_type": "distance from stomach",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "cm"
}
}
]
},
{
"exact_snippets": "No biopsy-proven invasion of the tracheal-bronchial tree",
"criterion": "invasion of the tracheal-bronchial tree",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No ... tracheal-esophageal (TE) fistula",
"criterion": "tracheal-esophageal (TE) fistula",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Bronchoscopy of tracheal-bronchial tree required for lesions less than 30 cm from the incisors",
"criterion": "bronchoscopy requirement",
"requirements": [
{
"requirement_type": "lesion distance from incisors",
"expected_value": {
"operator": "<",
"value": 30,
"unit": "cm"
}
}
]
},
{
"exact_snippets": "Negative liver biopsy required if liver CT suggestive of metastatic disease",
"criterion": "liver biopsy",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "Negative biopsy required for enlarged (1.5 cm or greater) retroperitoneal or celiac nodes seen on CT",
"criterion": "retroperitoneal or celiac nodes biopsy",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
},
{
"requirement_type": "node size",
"expected_value": {
"operator": ">=",
"value": 1.5,
"unit": "cm"
}
}
]
},
{
"exact_snippets": "Negative biopsy of clinically or radiographically positive supraclavicular nodes required with cervical primaries",
"criterion": "supraclavicular nodes biopsy",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "No recurrent disease",
"criterion": "recurrent disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No multiple carcinomas of the esophagus",
"criterion": "multiple carcinomas of the esophagus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "PRIOR CONCURRENT THERAPY: Biologic therapy: No prior or concurrent growth factor administration Chemotherapy: No prior chemotherapy Endocrine therapy: Not specified Radiotherapy: No prior chest irradiation Surgery: No prior resection",
"criterions": [
{
"exact_snippets": "No prior or concurrent growth factor administration",
"criterion": "growth factor administration",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior chest irradiation",
"criterion": "chest irradiation",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior resection",
"criterion": "resection",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": false
}
]
}
]
}
],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": [
{
"line": "PATIENT CHARACTERISTICS: Age: 18 and over Performance status: Karnofsky 60%-100% Hematopoietic: WBC at least 4,000 Platelets at least 150,000 Hb at least 10 g/dL Hepatic: Not specified Renal: Creatinine normal OR Creatinine clearance at least 65 mL/min Nutrition: Recommended oral intake requirements (by mouth or tube feeding): More than 1.5 x Basal Energy Expenditure (BEE) measured by Harris- Benedict equation OR More than 1,000 calories/sqm of body surface area (BSA) Intravenous hyperalimentation (recommended if inadequate oral intake): 1.75-2.25 x BEE OR 1,200-1,600 calories/sqm BSA Upper limits may be waived for hypermetabolic patients Other: No second malignancy within 5 years except: Curable nonmelanomatous skin cancer Cervical cancer in situ No pregnant or nursing women",
"criterions": [
{
"exact_snippets": "Age: 18 and over",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "Performance status: Karnofsky 60%-100%",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "Karnofsky score",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 60,
"unit": "%"
},
{
"operator": "<=",
"value": 100,
"unit": "%"
}
]
}
}
]
},
{
"exact_snippets": "Hematopoietic: WBC at least 4,000",
"criterion": "white blood cell count",
"requirements": [
{
"requirement_type": "minimum count",
"expected_value": {
"operator": ">=",
"value": 4000,
"unit": "cells/µL"
}
}
]
},
{
"exact_snippets": "Hematopoietic: ... Platelets at least 150,000",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "minimum count",
"expected_value": {
"operator": ">=",
"value": 150000,
"unit": "cells/µL"
}
}
]
},
{
"exact_snippets": "Hematopoietic: ... Hb at least 10 g/dL",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "minimum level",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "g/dL"
}
}
]
},
{
"exact_snippets": "Renal: Creatinine normal OR Creatinine clearance at least 65 mL/min",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "creatinine level",
"expected_value": "normal"
},
{
"requirement_type": "creatinine clearance",
"expected_value": {
"operator": ">=",
"value": 65,
"unit": "mL/min"
}
}
]
},
{
"exact_snippets": "Nutrition: Recommended oral intake requirements ... More than 1.5 x Basal Energy Expenditure (BEE) measured by Harris- Benedict equation OR More than 1,000 calories/sqm of body surface area (BSA)",
"criterion": "oral intake",
"requirements": [
{
"requirement_type": "energy intake",
"expected_value": [
"> 1.5 x BEE",
" > 1,000 calories/sqm BSA"
]
}
]
},
{
"exact_snippets": "Intravenous hyperalimentation ... 1.75-2.25 x BEE OR 1,200-1,600 calories/sqm BSA",
"criterion": "intravenous hyperalimentation",
"requirements": [
{
"requirement_type": "energy intake",
"expected_value": [
"1.75-2.25 x BEE",
"1,200-1,600 calories/sqm BSA"
]
}
]
},
{
"exact_snippets": "Other: No second malignancy within 5 years except: Curable nonmelanomatous skin cancer Cervical cancer in situ",
"criterion": "second malignancy",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
},
{
"requirement_type": "exceptions",
"expected_value": [
"Curable nonmelanomatous skin cancer",
"Cervical cancer in situ"
]
}
]
},
{
"exact_snippets": "Other: No pregnant or nursing women",
"criterion": "pregnancy or nursing status",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
}
]
}
]
}